New Results
Digitally-Supported Continuous Care Intervention Including Individualized Nutritional Ketosis Significantly Improves Surrogate Markers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Liver Fibrosis in Patients with Type 2 Diabetes: An Open Label, Non-Randomized, Controlled Study
Eduardo Vilar-Gomez, View ORCID ProfileShaminie J. Athinarayanan, Sarah J. Hallberg, Nasir H. Bhanpuri, Amy L. McKenzie, Wayne W. Campbell, James P. McCarter, Stephen D. Phinney, Jeff S. Volek, Naga Chalasani
doi: https://doi.org/10.1101/293548
Eduardo Vilar-Gomez
1Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA
Shaminie J. Athinarayanan
2Virta Health, 535 Mission Street, San Francisco, CA, USA
Sarah J. Hallberg
2Virta Health, 535 Mission Street, San Francisco, CA, USA
3Indiana University Health Arnett, Lafayette, IN
Nasir H. Bhanpuri
2Virta Health, 535 Mission Street, San Francisco, CA, USA
Amy L. McKenzie
2Virta Health, 535 Mission Street, San Francisco, CA, USA
Wayne W. Campbell
4Department of Nutrition Science, Purdue University, West Lafayette, IN, USA
James P. McCarter
2Virta Health, 535 Mission Street, San Francisco, CA, USA
5Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA
Stephen D. Phinney
2Virta Health, 535 Mission Street, San Francisco, CA, USA
Jeff S. Volek
2Virta Health, 535 Mission Street, San Francisco, CA, USA
6Department of Human Sciences, The Ohio State University, Columbus, OH, USA
Naga Chalasani
1Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN, USA
Posted April 05, 2018.
Digitally-Supported Continuous Care Intervention Including Individualized Nutritional Ketosis Significantly Improves Surrogate Markers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Liver Fibrosis in Patients with Type 2 Diabetes: An Open Label, Non-Randomized, Controlled Study
Eduardo Vilar-Gomez, Shaminie J. Athinarayanan, Sarah J. Hallberg, Nasir H. Bhanpuri, Amy L. McKenzie, Wayne W. Campbell, James P. McCarter, Stephen D. Phinney, Jeff S. Volek, Naga Chalasani
bioRxiv 293548; doi: https://doi.org/10.1101/293548
Digitally-Supported Continuous Care Intervention Including Individualized Nutritional Ketosis Significantly Improves Surrogate Markers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Liver Fibrosis in Patients with Type 2 Diabetes: An Open Label, Non-Randomized, Controlled Study
Eduardo Vilar-Gomez, Shaminie J. Athinarayanan, Sarah J. Hallberg, Nasir H. Bhanpuri, Amy L. McKenzie, Wayne W. Campbell, James P. McCarter, Stephen D. Phinney, Jeff S. Volek, Naga Chalasani
bioRxiv 293548; doi: https://doi.org/10.1101/293548
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)